LEADING THE OCTROTIDE SCALE-UP

Discover how Bachem revolutionized the production of octreotide acetate, a critical therapeutic peptide used in treating acromegaly. Our innovative, cost-effective, large-batch synthesis process meets the increasing demand for higher concentrations required by new therapies, ensuring better disease control and improved quality of life for patients.Key Highlights:Innovative Process: Learn about our cutting-edge approach to synthesizing octreotide acetate.Cost-Effective Solutions: See how we deliver high-quality API production at reduced costs.Successful Partnership: Explore our collaboration with a leading pharmaceutical company to scale up production.Gain insights into the challenges and solutions in large-scale API manufacturing, understand the benefits of partnering with Bachem for your pharmaceutical needs, and get inspired by a real-world example of successful industry collaboration. To download the entire resource, please complete the form.The post LEADING THE OCTROTIDE SCALE-UP appeared first on Bachem.Weiter zum vollständigen Artikel bei Bachem Holding AG Weiter zum vollständigen Artikel bei Bachem Holding AG